SCHEMBL7309370

SCHEMBL7309370

CC(C)(C)OC(=O)N1CCC2(CC1)COC2=O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
USP30 Q70CQ3 1/20 0.42
RECQL P46063 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HPGD P15428 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
EPHX2 P34913 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5375765 0.87 USP2 (0.55) USP2SMN1; SMN2USP30RECQLKDM4E
SCHEMBL24089120 0.81 USP2 (0.50) USP2SMN1; SMN2USP30RECQLKDM4E
SCHEMBL16914459 0.79 USP2 (0.50) USP2SMN1; SMN2USP30RECQLKDM4E
SCHEMBL20533859 0.79 USP2 (0.45) USP2SMN1; SMN2USP30KDM4EMAPT
SCHEMBL16914257 0.78 USP2 (0.45) USP2SMN1; SMN2USP30RECQLKDM4E
SCHEMBL18330214 0.78 USP2 (0.45) USP2SMN1; SMN2USP30RECQLKDM4E
SCHEMBL23002557 0.78 USP2 (0.45) USP2SMN1; SMN2USP30RECQLKDM4E
SCHEMBL16925372 0.78 USP2 (0.45) USP2SMN1; SMN2USP30RECQLKDM4E
SCHEMBL5895323 0.78 USP2 (0.47) USP2SMN1; SMN2USP30KDM4EMAPT
SCHEMBL9933565 0.77 USP2 (0.48) USP2SMN1; SMN2USP30RECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed